Evidence map›Paper›PMID 20215360›Full record

Trial reportBMJ (Clinical research ed.)2010

Vitamin A supplementation and BCG vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial.

Christine Stabell Benn, Ane Baerent Fisker, Bitiguida Mutna Napirna, Adam Roth, Birgitte Rode Diness, Karen Rokkedal Lausch, Henrik Ravn, Maria Yazdanbakhsh, Amabelia Rodrigues, Hilton Whittle and 1 more

Registry-linked trialOpen access · hybridAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in BMJ (Clinical research ed.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00168610 (Should Infants Receive High-dose Vitamin A Supplementation With BCG Vaccine at Birth in Developing Countries? Randomized Prospective Studies in Guinea-Bissau), which is not on this map. Cited by 49 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 8 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00168610 phase4unknown statusnot on this map

Should Infants Receive High-dose Vitamin A Supplementation With BCG Vaccine at Birth in Developing Countries? Randomized Prospective Studies in Guinea-Bissau

TypeinterventionalSponsorBandim Health ProjectRan2004Enrolled7,600ConditionsInfant Mortality, MorbidityArmsVitamin A
3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 8 syntheses or guidelines pooled it, 104 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Early BCG-Denmark and Neonatal Mortality Among Infants Weighing <2500 g: A Randomized Controlled Trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 5 countries.

Christine Stabell BennBandim Health Project, Statens Serum Institut, Copenhagen, Denmark. cb@ssi.dk
Ane Baerent Fisker
Bitiguida Mutna Napirna
Adam Roth
Birgitte Rode Diness
Karen Rokkedal Lausch
Henrik Ravn
Maria Yazdanbakhsh
Amabelia Rodrigues
Hilton Whittle
Peter Aaby
Bandim Health Project · GWStatens Serum Institut · DKLeiden University · NLLund University · SEMRC Unit the Gambia · GM

Funding

European Research Council 243149
6 · The paper itself

Abstract

objectiveTo investigate the effect of vitamin A supplementation and BCG vaccination at birth in low birthweight neonates.

designRandomised, placebo controlled, two by two factorial trial.

settingBissau, Guinea-Bissau.

participants1717 low birthweight neonates born at the national hospital.

interventionNeonates who weighed less than 2.5 kg were randomly assigned to 25 000 IU vitamin A or placebo, as well as to early BCG vaccine or the usual late BCG vaccine, and were followed until age 12 months.

main outcome measureMortality, calculated as mortality rate ratios (MRRs), after follow-up to 12 months of age for infants who received vitamin A supplementation compared with those who received placebo.

resultsNo interaction was observed between vitamin A supplementation and BCG vaccine allocation (P=0.73). Vitamin A supplementation at birth was not significantly associated with mortality: the MRR of vitamin A supplementation compared with placebo, controlled for randomisation to "early BCG" versus "no early BCG" was 1.08 (95% CI 0.79 to 1.47). Stratification by sex revealed a significant interaction between vitamin A supplementation and sex (P=0.046), the MRR of vitamin A supplementation being 0.74 (95% CI 0.45 to 1.22) in boys and 1.42 (95% CI 0.94 to 2.15) in girls. When these data were combined with data from a complementary trial among normal birthweight neonates in Guinea-Bissau, the combined estimate of the effect of neonatal vitamin A supplementation on mortality was 1.08 (95% CI 0.87 to 1.33); 0.80 (95% CI 0.58 to 1.10) in boys and 1.41 (95% CI 1.04 to 1.90) in girls (P=0.01 for interaction between neonatal vitamin A and sex).

conclusionsThe combined results of this trial and the complementary trial among normal birthweight neonates have now shown that, overall, it would not be beneficial to implement a neonatal vitamin A supplementation policy in Guinea-Bissau. Worryingly, the trials show that vitamin A supplementation at birth can be harmful in girls. Previous studies and future trials should investigate the possibility that vitamin A supplementation has sex differential effects. Trial registration ClinicalTrials.gov NCT00168610.

Indexed as

Infant, Low Birth WeightAdjuvants, ImmunologicBCG VaccineFemaleGuinea-BissauHumansInfantInfant MortalityInfant, NewbornInjections, IntradermalMalePrognosisSeasonsSurvival RateVitamin AVitamin A DeficiencyAdjuvants, ImmunologicBCG VaccineVitamin AVitamins

Identifiers

PMID20215360
PMCPMC2835853
OpenAlexW2073995237

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.